Benign prostatic hyperplasia (BPH) is a non-cancerous condition that commonly affects older men, causing lower urinary tract obstruction. The occurrence of BPH is directly related to age, with its prevalence increasing significantly as men grow older. Therefore, in clinical practice, the primary focus of treatment is to alleviate symptoms and slow the progression of the disease, as achieving a complete cure for BPH is relatively challenging. For mild cases of BPH without noticeable clinical symptoms, a conservative approach involving watchful waiting may be appropriate. However, for patients with more pronounced symptoms, pharmacological treatment is often necessary. The standard medication regimen typically includes 5-alpha reductase inhibitors and alpha-blockers. In cases of severe BPH accompanied by complications, surgical intervention is generally recommended, as it tends to yield more definitive and favorable outcomes.